Clinical relevance of molecular staging for melanoma: Comparison of RT- PCR and immunohistochemistry staining in sentinel lymph nodes of patients with melanoma

Annals of Surgery

Volumn 231, Issue 6, 2000, Pages 795-803

  Li, Weiguo ^a   Stall, Alec ^a   Shivers, Steven C ^a   Lin, Jeffrey ^a   Haddad, Fadi ^a   Messina, Jane ^a   Glass, L Frank ^a   Lyman, Gary ^a   Reintgen, Douglas S ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MALE; MELANOMA; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN NEOPLASMS;

EID: 0034082933     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-200006000-00003     Document Type: Article

References (22)

1. Kirkwood JM, Strawderman MH, Ernstoff MS, et al. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol 1996; 14:7-17.
2. Wong JH, Cagle LA, Morton DL. Lymphatic drainage of skin to a sentinel node in a feline model. Ann Surg 1991; 214:637-641.
3. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127:392-399.
4. Balch C, Soong SJ, Bartolucci AA, et al. Efficacy of an elective regional lymph node dissection of 1-4-mm-thick melanomas for patients 60 years of age and younger. Ann Surg 1996; 224:255-266.
5. Ross MI, Reintgen DS, Balch C. Selective lymphadenectomy: emerging role for lymphatic mapping and sentinel node biopsy in the management of early melanoma. Semin Surg Oncol 1993; 9:219-223.
6. Uren RF, Howman-Giles RB, Shaw HM, et al. Lymphoscintigraphy in high-risk melanoma of the trunk: predicting draining lymph node groups, defining lymphatic channels and locating the sentinel node. J Nucl Med 1993; 34:1435-1440.
7. Reintgen DS, Cruse CW, Wells K, et al. The orderly progression of melanoma nodal metastases. Ann Surg 1994; 220:759-767.
8. Krag DN, Meijer SJ, Weaver DL, et al. Minimal-access surgery for staging of malignant melanoma. Arch Surg 1995; 130:654-658.
9. Cochran AJ, Wen DR, Morton DL. Occult tumor cells in lymph nodes of patients with pathological stage I melanoma. Am J Surg Pathol 1988; 12:612-618.
10. Cho KH, Hashimoto K, Taniguchi Y, et al. Immunohistochemical study of melanocytic nevus and malignant melanoma with monoclonal antibodies against S-100 subunits. Cancer 1990; 66:765-771.
11. Messina J, Glass F. Pathologic examination of the sentinel lymph node. J Fla Med Assoc 1997; 84:153-156.
12. Kwon BS, Haq AK, Pomerantz SH, Halaban R. Isolation and sequence of a cDNA clone for human tyrosinase that maps at the mouse c-albino locus. Proc Natl Acad Sci USA 1987; 84:7473-7477.
13. Smith B, Selby P, Southgate J, et al. Detection of melanoma cells in peripheral blood by means of reverse-transcriptase and polymerase chain reaction. Lancet 1991; 338:1227-1229.
14. Wang X, Heller R, VanVoorhis N, et al. Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma. Ann Surg 1994; 220:768-774.
15. Fields KK, Elfenbein GJ, Trudeau WL, et al. Clinical significance of bone marrow metastases detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation. J Clin Oncol 1996; 6:1868-1876.
16. Shivers S, Wang X, Li W, et al. Molecular staging of malignant melanoma: correlation with clinical outcome. JAMA 1998; 280:1410-1415.
17. Berman C, Norman J, Cruse CW, et al. Lymphoscintigraphy in malignant melanoma. Ann Plast Surg 1992; 28:29-32.
18. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-481.
19. Mantel N. Evaluation of survival data and two new rank-order statistics arising in its consideration. Cancer Chemother Rep 1966; 50:163-170.
20. Cox D. Regression models and life tables. J R Stat Soc 1972; 34:187.
21. Balch CM, Cascinelli N, Drewiecki KT, et al. A comparison of prognostic factors world-wide. In: Balch CM, Houghton AN, Milton GW, Sober A, Soong S-J, eds. Cutaneous Melanoma, 2nd ed. Philadelphia: JB Lippincott; 1992:188.
22. Gershenwald J, Colome MI, Mansfield P, et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol 1998; 16:2253-2260.